These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7586929)

  • 1. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine.
    Hulsman JA; Rentmeester TW; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Radwanski E; Mojaverian P; Lin CC; Nezamis J
    Clin Pharmacol Ther; 1995 Oct; 58(4):383-9. PubMed ID: 7586929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of felbamate on the pharmacokinetics of phenobarbital.
    Reidenberg P; Glue P; Banfield CR; Colucci RD; Meehan JW; Radwanski E; Mojavarian P; Lin CC; Nezamis J; Guillaume M
    Clin Pharmacol Ther; 1995 Sep; 58(3):279-87. PubMed ID: 7554701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of felbamate on the pharmacokinetics of lamotrigine.
    Colucci R; Glue P; Holt B; Banfield C; Reidenberg P; Meehan JW; Pai S; Nomeir A; Lim J; Lin CC; Affrime MB
    J Clin Pharmacol; 1996 Jul; 36(7):634-8. PubMed ID: 8844446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of felbamate on carbamazepine and its major metabolites.
    Wagner ML; Remmel RP; Graves NM; Leppik IE
    Clin Pharmacol Ther; 1993 May; 53(5):536-43. PubMed ID: 8491065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.
    Glue P; Banfield CR; Perhach JL; Mather GG; Racha JK; Levy RH
    Clin Pharmacokinet; 1997 Sep; 33(3):214-24. PubMed ID: 9314612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.
    Saano V; Glue P; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Haring P; Radwanski E; Nomeir A; Lin CC
    Clin Pharmacol Ther; 1995 Nov; 58(5):523-31. PubMed ID: 7586946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of felbamate on plasma levels of carbamazepine and its metabolites.
    Albani F; Theodore WH; Washington P; Devinsky O; Bromfield E; Porter RJ; Nice FJ
    Epilepsia; 1991; 32(1):130-2. PubMed ID: 1985822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.
    Clemens PL; Cloyd JC; Kriel RL; Remmel RP
    Clin Drug Investig; 2007; 27(4):243-50. PubMed ID: 17358096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic interaction studies between felbamate and vigabatrin.
    Reidenberg P; Glue P; Banfield C; Colucci R; Meehan J; Rey E; Radwanski E; Nomeir A; Lim J; Lin C
    Br J Clin Pharmacol; 1995 Aug; 40(2):157-60. PubMed ID: 8562299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic drug interactions in children taking oxcarbazepine.
    Sallas WM; Milosavljev S; D'souza J; Hossain M
    Clin Pharmacol Ther; 2003 Aug; 74(2):138-49. PubMed ID: 12891224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
    Hooper WD; Franklin ME; Glue P; Banfield CR; Radwanski E; McLaughlin DB; McIntyre ME; Dickinson RG; Eadie MJ
    Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of pharmacokinetic interaction between oxcarbazepine and lamotrigine.
    Theis JG; Sidhu J; Palmer J; Job S; Bullman J; Ascher J
    Neuropsychopharmacology; 2005 Dec; 30(12):2269-74. PubMed ID: 16052246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
    Rouan MC; Lecaillon JB; Godbillon J; Menard F; Darragon T; Meyer P; Kourilsky O; Hillion D; Aldigier JC; Jungers P
    Eur J Clin Pharmacol; 1994; 47(2):161-7. PubMed ID: 7859804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felbamate: a new antiepileptic drug.
    Wagner ML
    Am J Hosp Pharm; 1994 Jul; 51(13):1657-66. PubMed ID: 7942890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy.
    Sachdeo RC; Narang-Sachdeo S; Montgomery PA; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    J Clin Pharmacol; 1998 Feb; 38(2):184-90. PubMed ID: 9549651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.
    Mecarelli O; Vicenzini E; Pulitano P; Vanacore N; Romolo FS; Di Piero V; Lenzi GL; Accornero N
    Ann Pharmacother; 2004 Nov; 38(11):1816-22. PubMed ID: 15367726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single and multiple dose pharmacokinetics of felbamate in the elderly.
    Richens A; Banfield CR; Salfi M; Nomeir A; Lin CC; Jensen P; Affrime MB; Glue P
    Br J Clin Pharmacol; 1997 Aug; 44(2):129-34. PubMed ID: 9278196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modeling to clinical trials.
    Graves NM; Ludden TM; Holmes GB; Fuerst RH; Leppik IE
    Pharmacotherapy; 1989; 9(6):372-6. PubMed ID: 2694113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.